Ana Flores, MD
Retina Specialist · Memphis, TNNPI 1346295565
Payments from drug & device makers
Across 346 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$925
- Harrow Eye, LLC$558
- Apellis Pharmaceuticals, Inc.$442
- Kala Pharmaceuticals, Inc.$386
- plus $3K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 132 | $2,587 |
| Regeneron Healthcare Solutions, Inc. | 22 | $1,158 |
| Sun Pharmaceutical Industries Inc. | 44 | $925 |
| Harrow Eye, LLC | 17 | $558 |
| Apellis Pharmaceuticals, Inc. | 9 | $442 |
| Kala Pharmaceuticals, Inc. | 23 | $386 |
| Novartis | 14 | $356 |
| Bausch & Lomb Americas Inc. | 12 | $350 |
| Oyster Point Pharma, Inc. | 16 | $345 |
| Eyevance Pharmaceuticals LLC | 9 | $257 |
| Mallinckrodt Hospital Products Inc. | 5 | $192 |
| Genentech USA, Inc. | 8 | $180 |
| Shire North American Group Inc | 3 | $160 |
| Sight Sciences, Inc. | 5 | $149 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $123 |
| Thrombogenics, Inc. | 2 | $61 |
| Tarsus Pharmaceuticals, Inc. | 2 | $55 |
| Dompe US, Inc. | 2 | $54 |
| Spark Therapeutics, Inc. | 2 | $46 |
| Thea Pharma Inc. | 2 | $43 |
| Alcon | 2 | $42 |
| Aerie Pharmaceuticals, Inc. | 2 | $38 |
| Omeros Corporation | 1 | $28 |
| Amgen | 2 | $27 |
| Alimera Sciences, Inc. | 1 | $25 |
| Eyepoint US, Inc. | 1 | $21 |
| AstraZeneca | 1 | $18 |
How this compares
$8,624 in reported general payments places this provider in the 50th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Memphis
- John ElfervigMemphis$1M
- Steven WilliamsMemphis$9K
- Andrew KraussMemphis$752
- Stephen HuddlestonGermantown$10.9M
- Steve CharlesGermantown$10.2M
- Carl AwhNashville$9.6M
- Eric SchneiderNashville$4M
- Brandon BusbeeNashville$1.7M
- Peter SonkinNashville$949K
- Akshay ThomasNashville$807K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.